United States · FDA National Drug Code directory

Novo Nordisk

Labeler · 69 source records

The organisation role is retained from the source. Companies with similar names in other sources are not automatically merged.

United States · Source reference 0169-2080_ff2589ac-650f-4740-984d-e950f785c1fc

Alhemo

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-2081_ff2589ac-650f-4740-984d-e950f785c1fc

Alhemo

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-2084_ff2589ac-650f-4740-984d-e950f785c1fc

Alhemo

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-8055_d47af230-b125-4bd9-b36c-51e8f90b22bc

ESPEROCT

KIT / Novo Nordisk

United States · Source reference 0169-8100_d47af230-b125-4bd9-b36c-51e8f90b22bc

ESPEROCT

KIT / Novo Nordisk

United States · Source reference 0169-8150_d47af230-b125-4bd9-b36c-51e8f90b22bc

ESPEROCT

KIT / Novo Nordisk

United States · Source reference 0169-8200_d47af230-b125-4bd9-b36c-51e8f90b22bc

ESPEROCT

KIT / Novo Nordisk

United States · Source reference 0169-8300_d47af230-b125-4bd9-b36c-51e8f90b22bc

ESPEROCT

KIT / Novo Nordisk

United States · Source reference 0169-8400_d47af230-b125-4bd9-b36c-51e8f90b22bc

ESPEROCT

KIT / Novo Nordisk

United States · Source reference 0169-8500_d47af230-b125-4bd9-b36c-51e8f90b22bc

ESPEROCT

KIT / Novo Nordisk

United States · Source reference 0169-3201_133d5f6e-b40f-47b6-ab47-10dc37114d79

Fiasp

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-3204_133d5f6e-b40f-47b6-ab47-10dc37114d79

Fiasp

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-3205_133d5f6e-b40f-47b6-ab47-10dc37114d79

Fiasp

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-3206_133d5f6e-b40f-47b6-ab47-10dc37114d79

Fiasp

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-2001_de82c22d-ea25-44ef-8bcd-c3cda9e84e59

Insulin Diluting Medium for NovoLog

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-1401_ed003972-d498-43fc-b809-05a47d86b8da

Macrilen

GRANULE, FOR SOLUTION / Novo Nordisk

United States · Source reference 0169-7810_590d35a4-6e12-450e-9508-0c5bbf2ac427

NOVOEIGHT

KIT / Novo Nordisk

United States · Source reference 0169-7815_590d35a4-6e12-450e-9508-0c5bbf2ac427

NOVOEIGHT

KIT / Novo Nordisk

United States · Source reference 0169-7820_590d35a4-6e12-450e-9508-0c5bbf2ac427

NOVOEIGHT

KIT / Novo Nordisk

United States · Source reference 0169-7825_590d35a4-6e12-450e-9508-0c5bbf2ac427

NOVOEIGHT

KIT / Novo Nordisk

United States · Source reference 0169-7830_590d35a4-6e12-450e-9508-0c5bbf2ac427

NOVOEIGHT

KIT / Novo Nordisk

United States · Source reference 0169-7850_590d35a4-6e12-450e-9508-0c5bbf2ac427

NOVOEIGHT

KIT / Novo Nordisk

United States · Source reference 0169-2100_de82c22d-ea25-44ef-8bcd-c3cda9e84e59

NOVOLOG

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-2101_de82c22d-ea25-44ef-8bcd-c3cda9e84e59

NOVOLOG

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-3303_de82c22d-ea25-44ef-8bcd-c3cda9e84e59

NOVOLOG

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-6338_de82c22d-ea25-44ef-8bcd-c3cda9e84e59

NOVOLOG

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-6339_de82c22d-ea25-44ef-8bcd-c3cda9e84e59

NOVOLOG

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-7501_de82c22d-ea25-44ef-8bcd-c3cda9e84e59

NOVOLOG

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-7703_b67c2419-4feb-4ce1-b97e-88760a8e1aee

Norditropin

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-7704_b67c2419-4feb-4ce1-b97e-88760a8e1aee

Norditropin

INJECTION, SOLUTION / Novo Nordisk

Browse companies in United States →